Recombinant DNA Technology Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Recombinant DNA Technology Market to 2027 - Global Analysis and Forecasts by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy, and Gene Editing), Application (Therapeutics, Agriculture, and Research), and Geography

Report Code: TIPRE00002969 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
Recombinant DNA Technology also known as rDNA technology is a process that involves joining of DNA molecules from different sources and inserting them into host organism that helps to produce products for human use. rDNA end products are used in science, medicine, agriculture and industry. This technology has led to transfer of desired characteristics that are used to improve the existing systems by controlling expression of target genes.

Rapid technological advancements in in genetic engineering and biotechnology techniques is expected to fuel the growth of the recombinant DNA technology market during the forecast period. In addition, increasing R&D expenditure and initiatives undertaken by market players for development of novel products is further expected to promote the growth of recombinant DNA technology market over the coming years. Moreover, development of products at lower costs is anticipated to offer growth opportunities in the recombinant DNA technology market.

The "Global Recombinant DNA Technology Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global market with detailed market segmentation by product type, application, and geography. The global recombinant DNA technology market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading recombinant DNA technology market players and offers key trends and opportunities in the market.

The global recombinant DNA technology market is segmented on the basis of product type and application. Based on product type, the recombinant DNA technology market is segmented into recombinant protein drugs, vaccines, genetically modified crops, expression systems, cell and gene therapy, and gene editing. On the basis of application, the global recombinant DNA technology market is segmented into therapeutics, agriculture, and research.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global recombinant DNA technology market based on product type, and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The recombinant DNA technology market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the recombinant DNA technology market in the coming years, owing to substantial presence of major players as well as high healthcare spending capacity in the region. On the other hand, Asia Pacific is expected to witness significant growth in the recombinant DNA technology market during the forecast period, due to presence of low-cost manufacturing centers and use of modern biotechnology tools for generation of novel products for agriculture and medicinal use in the region.

The report analyzes factors affecting recombinant DNA technology market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the recombinant DNA technology market in these regions.

The report also includes the profiles of key surgical lights companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the recombinant DNA technology market include, Thermo Fisher Scientific, Inc., Biogen, Sanofi, Merck KGaA, Pfizer, Inc., Amgen Inc., Monsanto Company, F. Hoffmann-La Roche, Novo Nordisk A/S, and GenScript among others.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Recombinant DNA Technology Market- By Product Type
1.3.2. Recombinant DNA Technology Market- By Application
1.3.3. Recombinant DNA Technology Market- By Region
1.3.3.1. By Country

2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT DNA TECHNOLOGY MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. RECOMBINANT DNA TECHNOLOGY MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. RECOMBINANT DNA TECHNOLOGY MARKET- GLOBAL ANALYSIS
6.1. RECOMBINANT DNA TECHNOLOGY MARKET - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT DNA TECHNOLOGY MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. PERFORMANCE OF KEY PLAYERS
6.4. EXPERT OPINIONS

7. RECOMBINANT DNA TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - BY PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. RECOMBINANT PROTEIN DRUGS MARKET
7.3.1. Overview
7.3.2. Recombinant Protein Drugs Market Forecasts and Analysis (US$ Mn)
7.3.3. Insulin Market
7.3.3.1. Overview
7.3.3.2. Insulin Market Forecasts and Analysis (US$ Mn)
7.3.4. Human Growth Hormone Market
7.3.4.1. Overview
7.3.4.2. Human Growth Hormone Market Forecasts and Analysis (US$ Mn)
7.3.5. Erythropoietin Market
7.3.5.1. Overview
7.3.5.2. Erythropoietin Market Forecasts and Analysis (US$ Mn)
7.3.6. Interferon Market
7.3.6.1. Overview
7.3.6.2. Interferon Market Forecasts and Analysis (US$ Mn)
7.3.7. Interferon Market
7.3.7.1. Overview
7.3.7.2. Interferon Market Forecasts and Analysis (US$ Mn)
7.3.8. Blood Factors Market
7.3.8.1. Overview
7.3.8.2. Blood Factors Market Forecasts and Analysis (US$ Mn)
7.3.9. Colony Stimulating Factors Market
7.3.9.1. Overview
7.3.9.2. Colony Stimulating Factors Market Forecasts and Analysis (US$ Mn)
7.3.10. Fusion Proteins Market
7.3.10.1. Overview
7.3.10.2. Fusion Proteins Market Forecasts and Analysis (US$ Mn)
7.3.11. Others Market
7.3.11.1. Overview
7.3.11.2. Others Market Forecasts and Analysis (US$ Mn)
7.4. VACCINES MARKET
7.4.1. Overview
7.4.2. Vaccines Market Forecast and Analysis (US$ Mn)
7.5. EXPRESSION SYSTEMS MARKET
7.5.1. Overview
7.5.2. Expression Systems Market Forecast and Analysis (US$ Mn)
7.5.3. Prokaryotic Cells Market
7.5.3.1. Overview
7.5.3.2. Prokaryotic Cells Market Forecasts and Analysis (US$ Mn)
7.5.4. Mammalian Cells Market
7.5.4.1. Overview
7.5.4.2. Mammalian Cells Market Forecast and Analysis (US$ Mn)
7.5.5. Yeast Market
7.5.5.1. Overview
7.5.5.2. Yeast Market Forecast and Analysis (US$ Mn)
7.5.6. Insects Market
7.5.6.1. Overview
7.5.6.2. Insects Market Forecast and Analysis (US$ Mn)
7.5.7. Others Market
7.5.7.1. Overview
7.5.7.2. Others Market Forecast and Analysis (US$ Mn)
7.6. CELL AND GENE THERAPY MARKET
7.6.1. Overview
7.6.1.1. Cell and Gene Therapy Market Forecast and Analysis (US$ Mn)
7.7. GENE EDITING MARKET
7.7.1. Overview
7.7.1.1. Gene Editing Market Forecast and Analysis (US$ Mn)

8. RECOMBINANT DNA TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. THERAPEUTICS MARKET
8.3.1. Overview
8.3.2. Therapeutics Market Forecast and Analysis (US$ Mn)
8.4. AGRICULTURE MARKET
8.4.1. Overview
8.4.2. Agriculture Market Forecast and Analysis (US$ Mn)
8.5. RESEARCH MARKET
8.5.1. Overview
8.5.2. Research Market Forecast and Analysis (US$ Mn)

9. RECOMBINANT DNA TECHNOLOGY MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA RECOMBINANT DNA TECHNOLOGY MARKET
9.1.1. North America Recombinant DNA Technology Market Forecasts and Analysis (US$ Mn)
9.1.2. North America Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.1.2.1. North America Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.1.2.2. North America Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.1.3. North America Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.1.4. North America Recombinant DNA Technology Market Forecasts and Analysis - By Country
9.1.5. US Market Overview
9.1.5.1. US Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.1.5.1.1. US Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.1.5.1.2. US Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.1.5.2. US Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.1.6. Canada Market Overview
9.1.6.1. Canada Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.1.6.1.1. Canada Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.1.6.1.2. Canada Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.1.6.2. Canada Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.1.7. Mexico Market Overview
9.1.7.1. Mexico Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.1.7.1.1. Mexico Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.1.7.1.2. Mexico Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.1.7.2. Mexico Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.2. EUROPE RECOMBINANT DNA TECHNOLOGY MARKET
9.2.1. Europe Recombinant DNA Technology Market Forecasts and Analysis (US$ Mn)
9.2.2. Europe Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.2.2.1. Europe Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.2.2.2. Europe Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.2.3. Europe Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.2.4. Europe Recombinant DNA Technology Market Forecasts and Analysis - By Country
9.2.5. UK Market Overview
9.2.5.1. UK Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.2.5.1.1. UK Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.2.5.1.2. UK Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.2.5.2. UK Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.2.6. Germany Market Overview
9.2.6.1. Germany Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.2.6.1.1. Germany Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.2.6.1.2. Germany Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.2.6.2. Germany Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.2.7. France Market Overview
9.2.7.1. France Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.2.7.1.1. France Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.2.7.1.2. France Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.2.7.2. France Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.3. ASIA PACIFIC RECOMBINANT DNA TECHNOLOGY MARKET
9.3.1. Asia Pacific Recombinant DNA Technology Market Forecasts and Analysis (US$ Mn)
9.3.2. Asia Pacific Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.3.2.1. Asia Pacific Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.3.2.2. Asia Pacific Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.3.3. Asia Pacific Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.3.4. Asia Pacific Recombinant DNA Technology Market Forecasts and Analysis - By Country
9.3.5. Japan Market Overview
9.3.5.1. Japan Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.3.5.1.1. Japan Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.3.5.1.2. Japan Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.3.5.2. Japan Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.3.6. China Market Overview
9.3.6.1. China Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.3.6.1.1. China Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.3.6.1.2. China Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.3.6.2. China Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.3.7. India Market Overview
9.3.7.1. India Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.3.7.1.1. India Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.3.7.1.2. India Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.3.7.2. India Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.4. MIDDLE EAST & AFRICA (MEA) RECOMBINANT DNA TECHNOLOGY MARKET
9.4.1. Middle East & Africa (MEA) Recombinant DNA Technology Market Forecasts and Analysis (US$ Mn)
9.4.2. Middle East & Africa (MEA) Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.4.2.1. Middle East & Africa Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.4.2.2. Middle East & Africa Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.4.3. Middle East & Africa (MEA) Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.4.4. Middle East & Africa (MEA) Recombinant DNA Technology Market Forecasts and Analysis - By Country
9.4.5. South Africa Market Overview
9.4.5.1. South Africa Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.4.5.1.1. South Africa Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.4.5.1.2. South Africa Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.4.5.2. South Africa Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.4.6. Saudi Arabia Market Overview
9.4.6.1. Saudi Arabia Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.4.6.1.1. Saudi Arabia Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.4.6.1.2. Saudi Arabia Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.4.6.2. Saudi Arabia Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.4.7. UAE Market Overview
9.4.7.1. UAE Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.4.7.1.1. UAE Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.4.7.1.2. UAE Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.4.7.2. UAE Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.5. SOUTH AND CENTRAL AMERICA RECOMBINANT DNA TECHNOLOGY MARKET
9.5.1. South and Central America Recombinant DNA Technology Market Forecasts and Analysis (US$ Mn)
9.5.2. South and Central America Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.5.2.1. South and Central America Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.5.2.2. South and Central America Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.5.3. South and Central America Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)
9.5.4. South and Central America Recombinant DNA Technology Market Forecasts and Analysis - By Country
9.5.5. Brazil Market Overview
9.5.5.1. Brazil Recombinant DNA Technology Market Forecasts and Analysis - By Product Type (US$ Mn)
9.5.5.1.1. Brazil Recombinant Protein Drugs Market Forecasts and Analysis - By Type (US$ Mn)
9.5.5.1.2. Brazil Expression Systems Market Forecasts and Analysis - By Type (US$ Mn)
9.5.5.2. Brazil Recombinant DNA Technology Market Forecasts and Analysis - By Application (US$ Mn)

10. INDUSTRY LANDSCAPE
10.1. ORGANIC GROWTH STRATEGIES
10.1.1. New Product Launches
10.1.2. Marketing & Promotional Activities
10.2. INORGANIC GROWTH STRATEGIES
10.2.1. Partnerships, Collaborations, and Joint Ventures
10.2.2. Mergers & Acquisitions

11. RECOMBINANT DNA TECHNOLOGY MARKET, KEY COMPANY PROFILES
11.1. THERMO FISHER SCIENTIFIC, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Financial Overview
11.1.4. Product Portfolio
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BIOGEN
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Financial Overview
11.2.4. Product Portfolio
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. SANOFI
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Financial Overview
11.3.4. Product Portfolio
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MERCK KGAA
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Financial Overview
11.4.4. Product Portfolio
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. PFIZER, INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Financial Overview
11.5.4. Product Portfolio
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. AMGEN INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Financial Overview
11.6.4. Product Portfolio
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MONSANTO COMPANY
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Financial Overview
11.7.4. Product Portfolio
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. F. HOFFMANN-LA-ROCHE
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Financial Overview
11.8.4. Product Portfolio
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVO NORDISK A/S
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Financial Overview
11.9.4. Product Portfolio
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. GENSCRIPT
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Financial Overview
11.10.4. Product Portfolio
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
12.3. RESEARCH METHODOLOGY
The List of Companies

1. Thermo Fisher Scientific, Inc.
2. Biogen
3. Sanofi
4. Merck KGaA
5. Pfizer, Inc.
6. Amgen Inc.
7. Monsanto Company
8. F. Hoffmann-La Roche
9. Novo Nordisk A/S
10. GenScript